New data supporting the safety and efficacy of tapinarof cream 1% (Vtama; Organon) for pediatric patients with atopic ...

Vaccination against COVID-19 could offer unexpected benefits for children suffering from eczema, a chronic skin condition ...

For actress, comedian, podcaster, and OPZELURA patient Heather McMahan, eczema struggles began as a child and have “been a ...

Women with breast cancer and preexisting atopic/allergic conditions faced a heightened risk for radiodermatitis up to 36 ...

An open-source platform enables multinational analysis of dermatology registries for atopic dermatitis while safeguarding ...

The ADHAND trial evaluates the efficacy and safety of tralokinumab in adult patients living with atopic dermatitis with ...

Siolta Therapeutics announces positive results from phase 2 ADORED study of STMC-103H to prevent atopic diseases: San Carlos, California Wednesday, November 19, 2025, 18:00 Hrs [I ...

Siolta Therapeutics, a clinical-stage biotech company developing first-in-class live biotherapeutic products (LBPs), today announced positive top-line results from the Phase 2 ADORED study (Allergic ...

Jeremy Rabe visits with TV super star, Tori Spelling, and Dr. Adam Friedman about treatment options for severe eczema. From ...

Peanut allergy is one of the most common food allergies, affecting between 1% and 2% of people living in the West. And, for ...

The National Allergy Council (NAC) has introduced allergy assist®, a web‑based advisory and education service designed to improve access to specialist allergy advice for general practitioners and ...

HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), a clinical-stage innovative drug development ...